Literature DB >> 10526317

Protein kinase C prevents oligodendrocyte differentiation: modulation of actin cytoskeleton and cognate polarized membrane traffic.

W Baron1, E J de Vries, H de Vries, D Hoekstra.   

Abstract

In a previous study, we showed that activation of protein kinase C (PKC) prevents oligodendrocyte differentiation at the pro-oligodendrocyte stage. The present study was undertaken to identify downstream targets of PKC action in oligodendrocyte progenitor cells. Activation of PKC induced the predominant phosphorylation of an 80-kD protein, identified as myristoylated alanine-rich C-kinase substrate (MARCKS). Upon phosphorylation, MARCKS is translocated from the plasma membrane to the cytosol. Furthermore, PKC activation perturbed the organization of the actin cytoskeleton, causing a redistribution of actin filaments to the submembranous or cortical actin cytoskeleton. As a consequence, transport of a protein traffic marker, the vesicular stomatitis virus glycoprotein, from the trans-Golgi network to the plasma membrane becomes perturbed. The effect of disruption of the actin filament network by cytochalasin D perfectly matched the effect of PKC. These data thus favor the existence of a causal relationship between actin rearrangement and docking and/or fusion of proteins to the plasma membrane. Interestingly, neither in control cells nor in PKC-activated cells did another protein traffic marker, influenza hemagglutinin (HA), reach the cell surface. However, an eminent and specific accumulation of HA just underneath the plasma membrane became apparent upon PKC activation. Yet, this effect could not be simulated by cytochalasin D treatment. Therefore, these observations imply that although MARCKS represents a prominent PKC target site in regulating differentiation, another target involves the differential control of cognate polarized trafficking pathways, which are apparently operating in oligodendrocyte progenitor cells. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526317     DOI: 10.1002/(sici)1097-4695(19991115)41:3<385::aid-neu7>3.0.co;2-e

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  9 in total

1.  The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins.

Authors:  Wia Baron; Sanford J Shattil; Charles ffrench-Constant
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

2.  Transcriptional expression of myelin basic protein in oligodendrocytes depends on functional syntaxin 4: a potential correlation with autocrine signaling.

Authors:  Marjolein Bijlard; Bert Klunder; Jenny C de Jonge; Anita Nomden; Sanjay Tyagi; Hans de Vries; Dick Hoekstra; Wia Baron
Journal:  Mol Cell Biol       Date:  2014-12-15       Impact factor: 4.272

3.  Myelin formation and remodeling.

Authors:  R Douglas Fields
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

4.  Myosin light chain kinase inhibitors induce retraction of mature oligodendrocyte processes.

Authors:  María G Thomas; Tomás A Santa Coloma; Jorge Correale; Graciela L Boccacci
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

5.  Functional involvement of protein kinase C-betaII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cells.

Authors:  D S Chappell; N A Patel; K Jiang; P Li; J E Watson; D M Byers; D R Cooper
Journal:  Diabetologia       Date:  2009-02-28       Impact factor: 10.122

6.  Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.

Authors:  Yasir A Syed; Chao Zhao; Don Mahad; Wiebke Möbius; Friedrich Altmann; Franziska Foss; G A González; Aycan Sentürk; Amparo Acker-Palmer; Gert Lubec; Kathryn Lilley; Robin J M Franklin; Klaus-A Nave; Mark R N Kotter
Journal:  Acta Neuropathol       Date:  2015-12-19       Impact factor: 17.088

7.  Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling.

Authors:  Alexandra S Baer; Yasir A Syed; Sung Ung Kang; Dieter Mitteregger; Raluca Vig; Charles Ffrench-Constant; Robin J M Franklin; Friedrich Altmann; Gert Lubec; Mark R Kotter
Journal:  Brain       Date:  2009-02       Impact factor: 13.501

8.  Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.

Authors:  Ginez A Gonzalez; Matthias P Hofer; Yasir A Syed; Ana I Amaral; Jon Rundle; Saifur Rahman; Chao Zhao; Mark R N Kotter
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

Review 9.  X MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and disease.

Authors:  Jon J Brudvig; Jill M Weimer
Journal:  Front Cell Neurosci       Date:  2015-10-13       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.